2 006 kr
Skickas inom 3-6 vardagar
2 006 kr
Skickas inom 3-6 vardagar
4 312 kr
Skickas inom 3-6 vardagar
3 903 kr
Skickas inom 3-6 vardagar
2 901 kr
Skickas inom 11-20 vardagar
3 493 kr
Skickas inom 3-6 vardagar
3 240 kr
Skickas inom 11-20 vardagar
1 311 kr
Skickas inom 3-6 vardagar
3 105 kr
Skickas inom 10-15 vardagar
2 531 kr
Skickas inom 3-6 vardagar
3 493 kr
Skickas inom 3-6 vardagar
3 275 kr
Skickas inom 3-6 vardagar
This is the first book of its kind to tie the metabolic syndrome with psychiatric disorders and raise the possibility that common antipsychotic treatments may have this type of adverse effect on patients. Presenting a complete overview and the relationship between insulin resistance syndrome and psychiatric and cognitive disorders, the book will be a welcome addition to the library of any psychiatrist, neurologist, endocrinologist, or research scientist. The book also discusses new treatments to help prevent metabolic complications among patients with neuropsychiatric illnesses, including schizophrenia, Alzheimer’s Disease, and major depression.
808 kr
Skickas inom 11-20 vardagar
Several antiepileptic drugs (AEDs) now have regulatory indications for treating bipolar disorder. There is growing evidence that AEDs in general have a variety of useful psychotropic effects. Antiepileptic Drugs to Treat Psychiatric Disorders is the first comprehensive, clinically oriented reference on the use of AEDs to treat a variety of psychiatric conditions such as mood, psychotic, anxiety, substance use, eating, and personality disorders. Written by the leading clinical experts, the book is organized by psychiatric disorder for easier information gathering, enabling physicians to use the text as a standalone reference.
2 901 kr
Skickas inom 11-20 vardagar
Today at least seven million children and adolescents are afflicted with Asperger’s disorder. Examining the etiology, diagnosis, and treatment of this condition, this volume provides the necessary guidance to psychiatrists and neurologists so they can correctly differentiate Asperger’s from other neurodevelopmental disorders. The book discusses brain morphology, chemistry, and function; related neuropathological findings; and screening instruments and imaging techniques. Also discussed are the genetics, epigenetics, and proteomics of Asperger's, relevant gene-environment interaction, social assimilation in the classroom, and biological treatment. Case studies enhance the text.
2 901 kr
Skickas inom 11-20 vardagar
Mood Disorders in Later Life examines the spectrum of mood disorders in older adults, focusing on major and nonmajor depressive disorders, bipolar disorder (manic and depressive phases), depression with psychotic features, and vascular depression. In depth discussions of diagnosis and treatment options including psychotherapy, pharmacotherapy, and ECT will help clinicians improve treatment outcomes in their elderly patients.
This Second Edition, an update and expansion of the 2003 Depression in Later Life, includes many additional topics including discussion of the epidemiology of late life mood disorders, the diagnosis and treatment of late life bipolar disorder, use of non-ECT neurotherapeutic approaches, and the importance of open access to the full range of treatments.
This comprehensive, single-source reference is ideal for all psychiatrists, neurologists, and primary care physicians and advanced practice nurses treating older adults.
Additional topics include:
overcoming barriers to treatmentcross-cultural issuesthe neurobiology of late life mood disordersmedical comorbiditydrug interactionsprevention of later life suicidemaintenance therapies4 312 kr
Skickas inom 3-6 vardagar
Edited by the president of the World Federation of Societies of Biological Psychiatry and featuring an international list of world-renown contributors, Schizophrenia, Second Edition provides psychiatrists, neurologists, and psychologists with a comprehensive handbook on the latest schizophrenia research and management from diagnosis through treatment.
New features in this user-friendly Second Edition:
Two-thirds new content, including 20 chapter additionsdetailed coverage of interviewing, symptomatology evaluation, and cognitive assessment strategies to ensure accurate differential diagnosisAn in-depth discussion of both pharmacological and nonpharmacological treatment optionsA section on the neurobiology of schizophrenia, covering the latest in genetic and epigenetic factors, brain abnormalities, neuroimaging, biochemical alterations, and social cognitionTreatment options for management of the disease, including treatment of the first schizophrenic episode, pharmacogenetic approaches, comparative efficacy of older vs. new antipsychotic medication, managing side-effects, psychosocial and cognitive rehabilitation, psychotherapy, and rehabilitation strategies4 312 kr
Skickas inom 3-6 vardagar
This updated and revised Second Edition provides a state-of-the-science review and clinical collection of research on treating depression with multiple therapies. The text is an essential guide for those who prescribe psychotropics or perform psychotherapy, including psychiatrists, residents, psychologists, and psychopharmacologists. Containing research data, case studies, and expert recommendations, this source explores the best acute, long-term, and combination treatment strategies for superior patient care.
New to the Second Edition:
a chapter devoted to a simultaneous discussion on psychotherapy and pharmacotherapychapters on depression and anxiety, depression and pain, and new treatment optionsinformation on the advancements of genetics, imaging, and brain stimulation with regard to depressive disorders and implications for future usethe latest research on drug development and combining drug treatments